Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing
Standard
Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing. / Seckam, Abdul M; Twardowska-Saucha, Krystyna; Heggemann, Jan; Süß-Burghart, Anja; Augustin, Matthias.
in: British journal of nursing (Mark Allen Publishing), Jahrgang 30, Nr. 5, 11.03.2021, S. S21-S30.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing
AU - Seckam, Abdul M
AU - Twardowska-Saucha, Krystyna
AU - Heggemann, Jan
AU - Süß-Burghart, Anja
AU - Augustin, Matthias
PY - 2021/3/11
Y1 - 2021/3/11
N2 - The aim of this prospective multicentre observational study was to assess the clinical performance and safety of Cutimed® Siltec® Sorbact® absorbent bacteria-binding foam dressing in wound healing and its impact on patients' quality of life (QoL). The study was conducted under routine clinical conditions in 5 study sites in Germany and Poland. Each patient with a venous leg ulcer (VLU) or a diabetic foot ulcer (DFU) was observed for 28 days (initial visit and close-out visit, as well as 3 control visits). An assessment of QoL of the patient was undertaken before and after the study. Sixty-two patients were included in the statistical analysis. Clinicians rated the following assessment parameters in relation to Cutimed Siltec Sorbact dressings as 'very good' to 'good': wearing comfort (rated by the patient), application and removal, exudate absorption with or without compression and fluid retention capacity with or without compression and infection management. The use of Cutimed Siltec Sorbact dressing was beneficial in absorbing wound exudate (chi-square=28.45, P value<0.001), reduction of the viscosity of wound exudate (chi-square=25.63, P value<0.001), and there were more intact, less macerated, red and oedematous wound surroundings. There was also a 9% decrease in the number of infected wounds at the close-out visit. Analysis of the Wound-QoL measures demonstrated a reduction in the perception of performance parameters associated with wound infection. It can therefore be deduced that the use of Cutimed Siltec Sorbact was effective in wound management and had positive implications for patients' QoL.
AB - The aim of this prospective multicentre observational study was to assess the clinical performance and safety of Cutimed® Siltec® Sorbact® absorbent bacteria-binding foam dressing in wound healing and its impact on patients' quality of life (QoL). The study was conducted under routine clinical conditions in 5 study sites in Germany and Poland. Each patient with a venous leg ulcer (VLU) or a diabetic foot ulcer (DFU) was observed for 28 days (initial visit and close-out visit, as well as 3 control visits). An assessment of QoL of the patient was undertaken before and after the study. Sixty-two patients were included in the statistical analysis. Clinicians rated the following assessment parameters in relation to Cutimed Siltec Sorbact dressings as 'very good' to 'good': wearing comfort (rated by the patient), application and removal, exudate absorption with or without compression and fluid retention capacity with or without compression and infection management. The use of Cutimed Siltec Sorbact dressing was beneficial in absorbing wound exudate (chi-square=28.45, P value<0.001), reduction of the viscosity of wound exudate (chi-square=25.63, P value<0.001), and there were more intact, less macerated, red and oedematous wound surroundings. There was also a 9% decrease in the number of infected wounds at the close-out visit. Analysis of the Wound-QoL measures demonstrated a reduction in the perception of performance parameters associated with wound infection. It can therefore be deduced that the use of Cutimed Siltec Sorbact was effective in wound management and had positive implications for patients' QoL.
KW - Bacteria
KW - Bandages
KW - Germany
KW - Humans
KW - Poland
KW - Prospective Studies
KW - Quality of Life
U2 - 10.12968/bjon.2021.30.5.S21
DO - 10.12968/bjon.2021.30.5.S21
M3 - SCORING: Journal article
C2 - 33733846
VL - 30
SP - S21-S30
JO - British journal of nursing (Mark Allen Publishing)
JF - British journal of nursing (Mark Allen Publishing)
SN - 0966-0461
IS - 5
ER -